SEARCH

SEARCH BY CITATION

References

  • Abib R. T., Peres K. C., Barbosa A. M. et al. (2011) Epigallocatechin-3-gallate protects rat brain mitochondria against cadmium-induced damage. Food Chem. Toxicol. 49, 26182623.
  • Akesson A., Bjellerup P., Lundh T., Lidfeldt J., Nerbrand C., Samsioe G., Skerfving S. and Vahter M. (2006) Cadmium-induced effects on bone in a population-based study of women. Environ. Health Perspect. 114, 830834.
  • Allison A. C., Cacabelos R., Lombardi V. R., Alvarez X. A. and Vigo C. (2001) Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 25, 13411357.
  • Bai X. and Jiang Y. (2010) Key factors in mTOR regulation. Cell. Mol. Life Sci. 67, 239253.
  • Boridy S., Soliman G. M. and Maysinger D. (2012) Modulation of inflammatory signaling and cytokine release from microglia by celastrol incorporated into dendrimer nanocarriers. Nanomedicine 7, 11491165.
  • Chen L., Liu L., Luo Y. and Huang S. (2008) MAPK and mTOR pathways are involved in cadmium-induced neuronal apoptosis. J. Neurochem. 105, 251261.
  • Chen L., Xu B., Liu L., Luo Y., Yin J., Zhou H., Chen W., Shen T., Han X. and Huang S. (2010) Hydrogen peroxide inhibits mTOR signaling by activation of AMPKalpha leading to apoptosis of neuronal cells. Lab. Invest. 90, 762773.
  • Chen G., Zhang X., Zhao M., Wang Y., Cheng X., Wang D., Xu Y., Du Z. and Yu X. (2011a) Celastrol targets mitochondrial respiratory chain complex I to induce reactive oxygen species-dependent cytotoxicity in tumor cells. BMC Cancer 11, 170.
  • Chen L., Xu B., Liu L., Luo Y., Zhou H., Chen W., Shen T., Han X., Kontos C. D. and Huang S. (2011b) Cadmium induction of reactive oxygen species activates the mTOR pathway, leading to neuronal cell death. Free Radic. Biol. Med. 50, 624632.
  • Chen S., Xu Y., Xu B. et al. (2011c) CaMKII is involved in cadmium activation of MAPK and mTOR pathways leading to neuronal cell death. J. Neurochem. 119, 11081118.
  • Choi H. J., Kang K. S., Fukui M. and Zhu B. T. (2011) Critical role of the JNK-p53-GADD45alpha apoptotic cascade in mediating oxidative cytotoxicity in hippocampal neurons. Br. J. Pharmacol. 162, 175192.
  • Cleren C., Calingasan N. Y., Chen J. and Beal M. F. (2005) Celastrol protects against MPTP- and 3-nitropropionic acid-induced neurotoxicity. J. Neurochem. 94, 9951004.
  • Deng Y. N., Shi J., Liu J. and Qu Q. M. (2013) Celastrol protects human neuroblastoma SH-SY5Y cells from rotenone-induced injury through induction of autophagy. Neurochem. Int. 63, 19.
  • Don A. S., Tsang C. K., Kazdoba T. M., D'Arcangelo G., Young W. and Zheng X. F. (2012) Targeting mTOR as a novel therapeutic strategy for traumatic CNS injuries. Drug Discov. Today 17, 861868.
  • Dumont M., Wille E., Calingasan N. Y. et al. (2009) Triterpenoid CDDO-methylamide improves memory and decreases amyloid plaques in a transgenic mouse model of Alzheimer's disease. J. Neurochem. 109, 502512.
  • Eybl V., Kotyzova D. and Koutensky J. (2006) Comparative study of natural antioxidants - curcumin, resveratrol and melatonin - in cadmium-induced oxidative damage in mice. Toxicology 225, 150156.
  • Flaherty D. M., Monick M. M. and Hinde S. L. (2006) Human alveolar macrophages are deficient in PTEN. The role of endogenous oxidants. J. Biol. Chem. 281, 50585064.
  • Hao B., Cheng S., Clancy C. J. and Nguyen M. H. (2013) Caspofungin kills Candida albicans by causing both cellular apoptosis and necrosis. Antimicrob. Agents Chemother. 57, 326332.
  • Huang S., Shu L., Dilling M., Easton J., Harwood F., Ichijo H. and Houghton P. (2003) Sustained activation of the JNK cascade and rapamycin-induced apoptosis are suppressed by p53/p21(Cip1). Mol. Cell 11, 14911501.
  • Jaquet V., Marcoux J., Forest E. et al. (2011) NADPH oxidase (NOX) isoforms are inhibited by celastrol with a dual mode of action. Br. J. Pharmacol. 164, 507520.
  • Jarup L., Persson B., Edling C. and Elinder C. G. (1993) Renal function impairment in workers previously exposed to cadmium. Nephron 64, 7581.
  • Jiang G., Xu L., Song S., Zhu C., Wu Q., Zhang L. and Wu L. (2008) Effects of long-term low-dose cadmium exposure on genomic DNA methylation in human embryo lung fibroblast cells. Toxicology 244, 4955.
  • Johri N., Jacquillet G. and Unwin R. (2010) Heavy metal poisoning: the effects of cadmium on the kidney. Biometals 23, 783792.
  • Kannaiyan R., Manu K. A., Chen L., Li F., Rajendran P., Subramaniam A., Lam P., Kumar A. P. and Sethi G. (2011) Celastrol inhibits tumor cell proliferation and promotes apoptosis through the activation of c-Jun N-terminal kinase and suppression of PI3 K/Akt signaling pathways. Apoptosis 16, 10281041.
  • Kiaei M., Kipiani K., Petri S., Chen J., Calingasan N. Y. and Beal M. F. (2005) Celastrol blocks neuronal cell death and extends life in transgenic mouse model of amyotrophic lateral sclerosis. Neurodegener. Dis. 2, 246254.
  • Kim S. D., Moon C. K., Eun S. Y., Ryu P. D. and Jo S. A. (2005) Identification of ASK1, MKK4, JNK, c-Jun, and caspase-3 as a signaling cascade involved in cadmium-induced neuronal cell apoptosis. Biochem. Biophys. Res. Commun. 328, 326334.
  • Kim Y., Kim K., Lee H., Han S., Lee Y. S., Choe J., Kim Y. M., Hahn J. H., Ro J. Y. and Jeoung D. (2009) Celastrol binds to ERK and inhibits FcepsilonRI signaling to exert an anti-allergic effect. Eur. J. Pharmacol. 612, 131142.
  • Kim S. J., Jung H. J. and Lim C. J. (2013) reactive oxygen species-dependent down-regulation of tumor suppressor genes PTEN, USP28, DRAM, TIGAR, and CYLD under oxidative stress. Biochem. Genet. doi:10.1007/s10528-013-9616-7.
  • Kocak M. and Akcil E. (2006) The effects of chronic cadmium toxicity on the hemostatic system. Pathophysiol. Haemost. Thromb. 35, 411416.
  • Koyu A., Gokcimen A., Ozguner F., Bayram D. S. and Kocak A. (2006) Evaluation of the effects of cadmium on rat liver. Mol. Cell. Biochem. 284, 8185.
  • Lee J. H., Won Y. S., Park K. H., Lee M. K., Tachibana H., Yamada K. and Seo K. I. (2012) Celastrol inhibits growth and induces apoptotic cell death in melanoma cells via the activation ROS-dependent mitochondrial pathway and the suppression of PI3K/AKT signaling. Apoptosis 17, 12751286.
  • Li Y., He D., Zhang X. et al. (2012) Protective effect of celastrol in rat cerebral ischemia model: down-regulating p-JNK, p-c-Jun and NF-kappaB. Brain Res. 1464, 813.
  • Lim S. and Clement M. V. (2007) Phosphorylation of the survival kinase Akt by superoxide is dependent on an ascorbate-reversible oxidation of PTEN. Free Radic. Biol. Med. 42, 11781192.
  • Liu L., Chen L., Chung J. and Huang S. (2008) Rapamycin inhibits F-actin reorganization and phosphorylation of focal adhesion proteins. Oncogene 27, 49985010.
  • Lopez E., Figueroa S., Oset-Gasque M. J. and Gonzalez M. P. (2003) Apoptosis and necrosis: two distinct events induced by cadmium in cortical neurons in culture. Br. J. Pharmacol. 138, 901911.
  • Mendez-Armenta M. and Rios C. (2007) Cadmium neurotoxicity. Environ. Toxicol. Pharmacol. 23, 350358.
  • Nordberg G. F. (1984) Chelating agents and cadmium toxicity: problems and prospects. Environ. Health Perspect. 54, 213218.
  • Okuda B., Iwamoto Y., Tachibana H. and Sugita M. (1997) Parkinsonism after acute cadmium poisoning. Clin. Neurol. Neurosurg. 99, 263265.
  • Panayi A. E., Spyrou N. M., Iversen B. S., White M. A. and Part P. (2002) Determination of cadmium and zinc in Alzheimer's brain tissue using inductively coupled plasma mass spectrometry. J. Neurol. Sci. 195, 110.
  • Pang X., Yi Z., Zhang J., Lu B., Sung B., Qu W., Aggarwal B. B. and Liu M. (2010) Celastrol suppresses angiogenesis-mediated tumor growth through inhibition of AKT/mammalian target of rapamycin pathway. Cancer Res. 70, 19511959.
  • Pihl R. O. and Parkes M. (1977) Hair element content in learning disabled children. Science 198, 204206.
  • Ravikumar B., Vacher C., Berger Z. et al. (2004) Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat. Genet. 36, 585595.
  • Renugadevi J. and Prabu S. M. (2010a) Cadmium-induced hepatotoxicity in rats and the protective effect of naringenin. Exp. Toxicol. Pathol. 62, 171181.
  • Renugadevi J. and Prabu S. M. (2010b) Quercetin protects against oxidative stress-related renal dysfunction by cadmium in rats. Exp. Toxicol. Pathol. 62, 471481.
  • Rockwell P., Martinez J., Papa L. and Gomes E. (2004) Redox regulates COX-2 upregulation and cell death in the neuronal response to cadmium. Cell. Signal. 16, 343353.
  • Salminen A., Lehtonen M., Paimela T. and Kaarniranta K. (2010) Celastrol: Molecular targets of Thunder God Vine. Biochem. Biophys. Res. Commun. 394, 439442.
  • Sinicropi M. S., Amantea D., Caruso A. and Saturnino C. (2010) Chemical and biological properties of toxic metals and use of chelating agents for the pharmacological treatment of metal poisoning. Arch. Toxicol. 84, 501520.
  • Sun H., Xu L., Yu P., Jiang J., Zhang G. and Wang Y. (2010) Synthesis and preliminary evaluation of neuroprotection of celastrol analogues in PC12 cells. Bioorg. Med. Chem. Lett. 20, 38443847.
  • Sunitha S., Nagaraj M. and Varalakshmi P. (2001) Hepatoprotective effect of lupeol and lupeol linoleate on tissue antioxidant defence system in cadmium-induced hepatotoxicity in rats. Fitoterapia 72, 516523.
  • Swiech L., Perycz M., Malik A. and Jaworski J. (2008) Role of mTOR in physiology and pathology of the nervous system. Biochim. Biophys. Acta 1784, 116132.
  • Thompson J. and Bannigan J. (2008) Cadmium: toxic effects on the reproductive system and the embryo. Reprod. Toxicol. 25, 304315.
  • Wang W. B., Feng L. X., Yue Q. X., Wu W. Y., Guan S. H., Jiang B. H., Yang M., Liu X. and Guo D. A. (2012) Paraptosis accompanied by autophagy and apoptosis was induced by celastrol, a natural compound with influence on proteasome, ER stress and Hsp90. J. Cell. Physiol. 227, 21962206.
  • Wright R. O., Amarasiriwardena C., Woolf A. D., Jim R. and Bellinger D. C. (2006) Neuropsychological correlates of hair arsenic, manganese, and cadmium levels in school-age children residing near a hazardous waste site. Neurotoxicology 27, 210216.
  • Xu Q., Huang M., Jin M. and Ren Q. (2007) LC-APCI-MS-MS for the determination of celastrol in human whole blood. Chromatographia 66, 735739.
  • Yang Y., Hou L., Li Y., Ni J. and Liu L. (2013) Neuronal necrosis and spreading death in a Drosophila genetic model. Cell Death Dis. 4, e723.
  • Yu X., Tao W., Jiang F., Li C., Lin J. and Liu C. (2010) Celastrol attenuates hypertension-induced inflammation and oxidative stress in vascular smooth muscle cells via induction of heme oxygenase-1. Am. J. Hypertens. 23, 895903.
  • Zhang J., Li C. Y., Xu M. J., Wu T., Chu J. H., Liu S. J. and Ju W. Z. (2012) Oral bioavailability and gender-related pharmacokinetics of celastrol following administration of pure celastrol and its related tablets in rats. J. Ethnopharmacol. 144, 195200.
  • Zhu H., Liu X. W., Cai T. Y., Cao J., Tu C. X., Lu W., He Q. J. and Yang B. (2010) Celastrol acts as a potent antimetastatic agent targeting beta1 integrin and inhibiting cell-extracellular matrix adhesion, in part via the p38 mitogen-activated protein kinase pathway. J. Pharmacol. Exp. Ther. 334, 489499.